Top Markets
#1 MowCat MowCat +49.05%
#2 Velvet Velvet +36.37%
#3 Audiera Audiera +22.76%
#4 Derive Derive +20.53%
#5 Bermuda Shorts Bermuda Shorts +18.78%
#6 Quack AI Quack AI +18.60%
#7 MarsCoin MarsCoin +16.83%
#8 aPriori aPriori +15.97%
#9 Biconomy Biconomy +13.11%
#10 Cross Cross +11.62%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Rang in Aktien #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Aktienkurs
$2.37
Zuletzt synchronisiert: 2025-12-15
Marktkapitalisierung
$3.99M
Veränderung (1 Tag)
-5.58%
Veränderung (1 Jahr)
24.74%
Land
US
Handel Qualigen Therapeutics, Inc. (QLGN)

Kategorie

Healthcare
Aktien-Split-Historie für Qualigen Therapeutics, Inc. (QLGN)
Die Aktie Qualigen Therapeutics, Inc. (Symbol: QLGN) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 16, 2026 statt.
Eine QLGN-Aktie, die vor dem Aug 16, 2026 gekauft wurde, entspricht heute 0 QLGN-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE